Home / Products / Genome-edited Cells / DNAJA1 Knockout Caco-2 Cell Line

DNAJA1 Knockout Caco-2 Cell Line

Cat. No. ARG43818
Product Type:

In Stock Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Large intestine (colon)

Growth Properties:

Adherent

In stock
Request a Quote

Short Description

The DNAJA1 Knockout Caco-2 Cell Line is a CRISPR/Cas9-edited knockout cell line that disrupts the co-chaperone DNAJA1 in the Caco-2 human colorectal adenocarcinoma model. DNAJA1, an Hsp40 family member, regulates Hsp70-mediated protein folding and degradation, interacting with HSF1, BAG3, and CHIP. This loss-of-function model is ideal for dissecting proteostasis and stress responses in intestinal epithelia, with applications in cancer and neurodegenerative disease research. Key techniques include chaperone expression profiling, client co-immunoprecipitation, and stress survival assays. Contact Ascent Research for support.

Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Species:
Homo sapiens (Human)
Tissue Source:
Large intestine (colon)
Disease:
Adenocarcinoma
Morphology:
Epithelial-like
Growth Properties:
Adherent
Donor Age:
72 years
Donor Sex:
Male

Cell Engineering Information

Gene Name:
DNAJA1
Gene Identifier:
NCBI Gene ID 3301

Immortalization Information

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Sterility testing:
The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description

The DNAJA1 Knockout Caco-2 Cell Line is a CRISPR/Cas9-edited knockout cell line derived from the human colorectal adenocarcinoma Caco-2 cell line, with targeted disruption of the DNAJA1 gene leading to loss of its co-chaperone function. This model provides a defined system for investigating DNAJA1-dependent mechanisms in proteostasis within an intestinal epithelial background.

The parental Caco-2 cell line, established from a colon carcinoma, is widely used as an in vitro model of the intestinal epithelial barrier. Upon achieving confluence, Caco-2 cells spontaneously differentiate into a polarized, enterocyte-like monolayer, forming tight junctions and expressing brush border enzymes. This well-characterized system enables studies of intestinal biology, transport, and stress physiology.

DNAJA1, a member of the Hsp40 family, functions as a crucial co-chaperone that recruits Hsp70/Hsc70 to client proteins, facilitating their proper folding, trafficking, and degradation. Its expression is activated by HSF1 under stress conditions such as heat or oxidative challenge. DNAJA1 interacts with Hsp70, BAG family proteins (e.g., BAG3), and the E3 ligase CHIP to coordinate protein triage: refolding or proteasomal clearance. Disruption of DNAJA1 derails the Hsp70 chaperone cycle, causing accumulation of misfolded proteins and compromised cellular protein quality control.

In Caco-2 cells, DNAJA1 knockout imposes proteotoxic stress, mirroring pathologies where chaperone systems are overwhelmed, such as colorectal cancer and inflammatory bowel disease. The model enables dissection of how co-chaperone dysfunction influences epithelial barrier integrity, unfolded protein responses, and stress resilience. Given the constant environmental challenges faced by intestinal epithelia, this system is valuable for exploring how proteostasis disruption contributes to disease progression and intestinal homeostasis.

Key applications include profiling chaperone and stress gene expression by western blotting and RT-qPCR, measuring protein folding using luciferase-based reporters, and co-immunoprecipitation of Hsp70-client complexes. The cell line supports functional assays of cell viability under thermal or oxidative stress, proteasome activity, and autophagy flux analysis to evaluate aggregate clearance. It further serves as a screening platform for modulators of Hsp70?CDNAJA1 interactions, with potential implications in cancer and neurodegeneration therapeutics. For inquiries, contact Ascent Research.